Supplemental material, sj-csv-2-onc-10.1177_11795549231203142 for Clinical Features and Outcomes of Primary Breast Diffuse Large B-Cell Lymphoma: A Matched-Pair Study by Ling-Chiao Teng, Yu-Min Liao,
RationalWhile a variety of registered therapies exist for Cutaneous T Cell Lymphoma, no such therapy is available for Cutaneous B Cell Therapy. In this context we performed a phase II, open label, mul
Tumor infiltrating neutrophils (TAN) have been shown to exert both pro- and anti-tumoral activities and their recruitment and polarization are triggered by tumor-derived signals. Resident mesenchymal
1Among 3,315 assessable patients in our data base, 209 died early, due to early toxic death (n = 163, 4.9%), other cancers (n = 8, 0.2%), unknown reasons (n = 17), probable but not formally proven lym
Eumyc lymphoma was inoculated i.v. into C57BL/6J mice. Spleens were harvested from healthy or Emyc lymphoma-bearing mice at day 14 post-inoculation, and splenic NK cells were purfied using flow cytome
